文献速递哮喘慢阻肺

从不吸烟哮喘患者持续性呼气气流阻塞中未疑及肺气肿的进一步研究

Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
PubMed 文献 · Chest · 2017-11-29

本前瞻性研究对25例从不吸烟的慢性哮喘患者随访5至22年,发现所有患者均有静态肺弹性回缩力丧失,且与内源性气道传导率下降共同限制呼气气流;肺CT仅见无或轻度肺气肿,但5例尸检或移植肺显微镜下均见未疑及的轻度弥漫性小叶中央型肺气肿。

要点

  • 从不吸烟的慢性哮喘患者可存在未疑及的显微镜下轻度小叶中央型肺气肿。
  • 肺弹性回缩力丧失与内源性气道传导率下降共同导致呼气气流阻塞。
  • 肺CT和弥散功能可近正常,不能排除显微镜下肺气肿。

核心结论

  • 未疑及的显微镜下轻度小叶中央型肺气肿是肺弹性回缩力丧失的前哨原因,显著 contribuir 从不吸烟哮喘患者的呼气气流阻塞。

研究设计与样本

  • 前瞻性研究,纳入25例(12例女性)从不吸烟的慢性哮喘患者,年龄55±15岁,持续中重度呼气阻塞,随访5至22年。

主要发现

  • 25例患者吸入270 μg硫酸沙丁胺醇后FVC为3.1±1.0 L(83%±13%预计值),FEV1为1.8±0.6 L(59%±11%),FEV1/FVC比为59%±10%,DLCO/VA为4.8±1.1 mL/min/mm Hg/L(120%±26%)。
  • 所有25例哮喘患者均有静态肺弹性回缩压丧失,与内源性气道传导率下降同等程度地限制呼气气流。
  • 肺CT扫描未检出或仅见轻度肺气肿;5例(4例尸检肺及1例未报告移植肺)显微镜下见未疑及的轻度弥漫性小叶中央型肺气肿,位于上、中肺野,并见哮喘相关气道重塑。
  • 8例患者在哮喘缓解期,静态肺弹性回缩压、计算的内源性气道传导率及努力非依赖性肺容积下的最大呼气气流均增加。

临床怎么用

  • 对从不吸烟的慢性哮喘伴持续呼气气流阻塞者,应考虑到显微镜下肺气肿导致肺弹性回缩力丧失的可能。
  • 肺CT近正常和弥散功能正常不能排除显微镜下小叶中央型肺气肿。

局限性

  • 显微镜下肺气肿证据仅来自5例(4例尸检和1例移植肺),样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previously, we and other investigators have described reversible loss of lung elastic recoil in patients with acute and persistent, moderate-to-severe, chronic, treated asthma who never smoked, and its adverse effect on maximal expiratory airflow. In four consecutive autopsies, we reported the pathophysiologic mechanism(s) has been unsuspected mild, diffuse, middle and upper lobe centrilobular emphysema. METHODS: We performed prospective studies (5 to 22 years) in 25 patients (12 female) with chronic asthma, age 55 ± 15 years, who never smoked, with persistent moderate-to-severe expiratory obstruction. Studies included measuring blood eosinophils, IgE, total exhaled nitric oxide (NO), central airway NO flux, peripheral airway/alveolar NO concentration, impulse oscillometry, heliox curves, lung elastic recoil, and high-resolution thin-section (1 mm) lung CT imaging at full inspiration with voxel quantification. RESULTS: In 25 patients with stable asthma with varying type 2 phenotype, after 270 μg of aerosolized albuterol sulfate had been administered with a metered dose inhaler with space chamber, FVC was 3.1 ± 1.0 L (83% ± 13% predicted) (mean ± SD), FEV1 was 1.8 ± 0.6 L (59% ± 11%), the FEV1/FVC ratio was 59% ± 10%, and the ratio of single-breath diffusing capacity of the lung for carbon monoxide to alveolar volume was 4.8 ± 1.1 mL/min/mm Hg/L (120% ± 26%). All 25 patients with asthma had loss of static lung elastic recoil pressure, which contributed equally to decreased intrinsic airway conductance in limiting expiratory airflow. Lung CT scanning detected none or mild emphysema. In all four autopsied asthmatic lungs previously reported and one unreported explanted lung, microscopy revealed unsuspected mild, diffuse centrilobular emphysema in the upper and middle lung fields, and asthma-related remodeling in airways. In eight cases, during asthma remission, there were increases in measured static lung elastic recoil pressure-calculated intrinsic airway conductance, and measured maximal expiratory airflow at effort-independent lung volumes. CONCLUSIONS: As documented now in five cases, unsuspected microscopic mild centrilobular emphysema is the sentinel cause of loss of lung elastic recoil. This contributes significantly to expiratory airflow obstruction in never-smoking patients with asthma, with normal diffusing capacity and near-normal lung CT scan results. TRIAL REGISTRY: Protocol No. 20070934 and Study No. 1090472, Western Institutional Review Board, Olympia, WA; ClinicalTrials.gov; No. NCT00576069; URL: www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Gelb AF, Yamamoto A, Verbeken EK, et al. Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction. Chest. 2017. PMID: 29197547. doi:10.1016/j.chest.2017.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。